7 épisodes

Worldwide Clinical Trials employs more than 1,600 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia, and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, immune-mediated inflammatory disorders (IMID), oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit http://www.worldwide.com.

Uncommon Conversations by Worldwide Clinical Trials Worldwide Clinical Trials

    • Forme et santé

Worldwide Clinical Trials employs more than 1,600 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia, and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, immune-mediated inflammatory disorders (IMID), oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit http://www.worldwide.com.

    • video
    Secrets to Funding Success: A Podcast Interview with Lars Wilde, Co-Founder & COO, Compass Pathways

    Secrets to Funding Success: A Podcast Interview with Lars Wilde, Co-Founder & COO, Compass Pathways

    Co-Founder and COO of Compass Pathways, Lars Wilde, discusses his journey to secure funding for his psilocybin therapy for treatment-resistant depression. What made him so successful? Listen now to find out.

    • 19 min
    Addressing Investor Risks

    Addressing Investor Risks

    Investors expressed two risks to Peter Strumph regarding his pitch. In this episode, Peter talks about how he addressed and overcame these risks during funding conversations, and the lessons he learned along the way.

    • 5 min
    Innovation: Do Investors Really Care?

    Innovation: Do Investors Really Care?

    In this episode, Peter reveals what surprised him most: the buzz surrounding innovation. So many people claim that it makes or breaks a funding deal, but does it? Peter talks about how he approached this when preparing his funding strategy.

    • 5 min
    Producing a Winning Presentation

    Producing a Winning Presentation

    What kind of presentation intrigues investors? What parts of Peter’s presentation were so successful? Uncover how one pharmaceutical executive created a presentation that ultimately won the business of investors.

    • 4 min
    • video
    How to Manage the Challenges in Early Phase Oncology Clinical Trials

    How to Manage the Challenges in Early Phase Oncology Clinical Trials

    Meghann Howland, Vice President, Therapeutic Strategy Lead, Oncology, at Worldwide Clinical Trials, discusses the challenges of managing an early phase oncology clinical trial, and how the right contract research organization (CRO) can be a valuable asset.

    • 5 min
    • video
    Alzheimer’s Disease: We’re Not About to Give Up Now

    Alzheimer’s Disease: We’re Not About to Give Up Now

    The scientific, medical, and operational experts at Worldwide Clinical Trials’ have been leading Alzheimer’s disease research since the advent of cholinesterase inhibitors as a cognitive therapeutic in the late 1970s. It’s been a long road on the way to finding a cure for Alzheimer’s disease and related dementias. And we’re not about to give up now. In this video, Dr. Michael Murphy, Chief Medical and Scientific Officer at Worldwide Clinical Trials, shares his thoughts on understanding the complexities in evaluating patients with various phenotypes, and implementing study design features in Alzheimer’s disease trials that mitigate risks and challenges.

    • 4 min

Classement des podcasts dans Forme et santé